Our latest research, company updates and industry insight
LID-Monitor is being used in a study by University of York and Rui Jin Hospital in Shanghai into the treatment of people with Parkinson’s within China.
ClearSky Medical Diagnostics is thrilled to announce its selection to take part in a Duke of York initiative that supports innovative businesses and accelerates their business ideas – the Pitch@Palace competition.
2019 is underway with exciting plans to launch new products and clinical trials, let’s take a look back at some of the recent highlights for ClearSky MD.
ClearSky Medical Diagnostic’s research workshop on improving machine learning was a success. Attended by our clinical partners at Leeds General Infirmary in December, including neurologists and specialists in neurodegenerative diseases.
We’re delighted to welcome Xiang Li to the ClearSky Medical Diagnostics team – she joined us on a 3-month internship in December. Xiang will be based at the ClearSky MD’s headquarters at the University of York. My name is Xiang Li and I recently finished my MSc in...
Professor Stephen Smith travelled to Bangalore in November to co-lead a tutorial at the 2018 IEEE Symposium Series on Computational Intelligence (IEEE SSCI 2018). IEEE SSCI 2018 is an annual international conference organised by the IEEE Computational Intelligence...
The ClearSky Medical Diagnostics team attended an event in Leeds in November celebrating collaboration and innovation in developing new medical technologies across the region.
ClearSky Medical Diagnostics will be heading to Hong Kong in October for the 22nd International Congress of Parkinson’s Disease and Movement Disorders (MDS).
ClearSky’s PD-Monitor can be used to confirm the diagnosis of Parkinson’s in very early stages based on the presence of bradykinesia in the dominant affected side, according to a groundbreaking study in China.
ClearSky Medical Diagnostics is proud to be part of an award-winning team that scooped top prize in the Human-Competitive Awards (Humies) 2018 in Japan.
Members of the ClearSky team are finalists in the Human-Competitive Awards at the 2018 Genetic & Evolutionary Computation Conference (GECCO) in Japan.
ClearSky’s co-founder and director Professor Stephen Smith was recently awarded a secondment to evaluate the technology for measuring the symptoms of Parkinson’s. Professor Stephen Smith, Deputy Head of the Department of Electronic Engineering at the University of...